Skip to Content

CNN – Health

Two House committees have launched an investigation into the approval and pricing of the Alzheimer's disease drug aducanumab

US lawmakers launch investigation into FDA approval and price of new Alzheimer’s drug

By Jacqueline Howard, CNN Two House committees have launched an investigation into the approval and pricing of the Alzheimer’s disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm. The US Food and Drug Administration approved the drug earlier this month under its “accelerated approval” program, although an FDA advisory

Continue Reading

US lawmakers launch investigation into FDA approval and price of new Alzheimer’s drug

By Jacqueline Howard, CNN Two House committees have launched an investigation into the approval and pricing of the Alzheimer’s disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm. The US Food and Drug Administration approved the drug earlier this month under its “accelerated approval” program, although an FDA advisory

Continue Reading
Skip to content